EGFR-IN-134
EGFR-IN-134 is a potent triazoloquinoline-based EGFR inhibitor (IC50: 0.023 μM) that exhibits anticancer activity by inducing apoptosis, necrosis, and G2/M cell cycle arrest. It modulates key apoptotic proteins, including downregulating Bcl-2 and upregulating p53, Bax, and caspases. This compound is a valuable tool for in vitro cancer research, particularly in studying EGFR-driven proliferation and cell death mechanisms.
Product Specifications
Field of Research
Cardiovascular Research, Cell Biology, Protein Biochemistry, Signal Transduction
Smiles
O=C (C1=NN (C2=CC=C ([N+] ([O-]) =O) C=C2) C3N1CCC4=C3C=C (OC) C (OC) =C4) /C=C/C5=CN (C6=CC=CC=C6) N=C5C7=CC=CC=C7
Molecular Formula
C36H30N6O5
Molecular Weight
626.66
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
21117121 3x 1.0µg DNA
FZR1 CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 
133268-ML650 100 µL
SGOL1 (Shugoshin-like 1, SGO1, SGO, hSgo1, Serologically Defined Breast Cancer Antigen NY-BR-85) (MaxLight 650)
Sign In for Pricing
View Details